Trial NCT01050764

View at ClinicalTrials.gov 
Org. Study IDs: IRB-15919
Secondary IDs: BMT204 SU-03312009-2059

Last trial update was posted on 2018-06-27

MeSH Interventions

Antilymphocyte Serum Fludarabine Fludarabine phosphate Melphalan Thiotepa Thymoglobulin Vidarabine

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Leukemia, Myeloid, Acute Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma Preleukemia

Other Conditions

Acute Lymphoblastic Leukemia (ALL) Acute Myelogenous Leukemia (AML) Chronic Lymphocytic Leukemia (CLL) Chronic Myelogenous Leukemia (CML) Leukemia, Acute Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL)

Stopping Reasons

Safety

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID